BioSyent Statistics
Total Valuation
BioSyent has a market cap or net worth of 96.33 million. The enterprise value is 83.89 million.
| Market Cap | 96.33M |
| Enterprise Value | 83.89M |
Important Dates
The next estimated earnings date is Friday, May 23, 2025.
| Earnings Date | May 23, 2025 |
| Ex-Dividend Date | May 30, 2025 |
Share Statistics
| Current Share Class | 11.47M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -6.39% |
| Shares Change (QoQ) | -3.68% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 8.79M |
Valuation Ratios
The trailing PE ratio is 17.70.
| PE Ratio | 17.70 |
| Forward PE | n/a |
| PS Ratio | 3.62 |
| PB Ratio | 3.84 |
| P/TBV Ratio | 4.46 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 15.42 |
| EV / Sales | 3.07 |
| EV / EBITDA | 11.20 |
| EV / EBIT | 11.81 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.90
| Current Ratio | 4.90 |
| Quick Ratio | 3.90 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 167.92 |
Financial Efficiency
Return on equity (ROE) is 22.17% and return on invested capital (ROIC) is 17.31%.
| Return on Equity (ROE) | 22.17% |
| Return on Assets (ROA) | 15.00% |
| Return on Invested Capital (ROIC) | 17.31% |
| Return on Capital Employed (ROCE) | 26.91% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.93 |
| Inventory Turnover | 1.50 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +30.24% in the last 52 weeks. The beta is 0.45, so BioSyent's price volatility has been lower than the market average.
| Beta (5Y) | 0.45 |
| 52-Week Price Change | +30.24% |
| 50-Day Moving Average | 7.71 |
| 200-Day Moving Average | 7.81 |
| Relative Strength Index (RSI) | 76.77 |
| Average Volume (20 Days) | 1,900 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioSyent had revenue of 26.63 million and earned 5.44 million in profits. Earnings per share was 0.48.
| Revenue | 26.63M |
| Gross Profit | 20.91M |
| Operating Income | 6.91M |
| Pretax Income | 7.33M |
| Net Income | 5.44M |
| EBITDA | 7.22M |
| EBIT | 6.91M |
| Earnings Per Share (EPS) | 0.48 |
Balance Sheet
The company has 12.11 million in cash and n/a in debt, giving a net cash position of 12.11 million.
| Cash & Cash Equivalents | 12.11M |
| Total Debt | n/a |
| Net Cash | 12.11M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 25.05M |
| Book Value Per Share | 2.22 |
| Working Capital | 15.86M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 78.51%, with operating and profit margins of 25.95% and 20.43%.
| Gross Margin | 78.51% |
| Operating Margin | 25.95% |
| Pretax Margin | 27.52% |
| Profit Margin | 20.43% |
| EBITDA Margin | 27.12% |
| EBIT Margin | 25.95% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 0.13, which amounts to a dividend yield of 1.57%.
| Dividend Per Share | 0.13 |
| Dividend Yield | 1.57% |
| Dividend Growth (YoY) | 7.56% |
| Years of Dividend Growth | 3 |
| Payout Ratio | n/a |
| Buyback Yield | 6.39% |
| Shareholder Yield | 7.97% |
| Earnings Yield | 5.65% |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |